摘要
Aim: The prediction model of postoperative survival for single large and huge hepatocellular carcinoma (SLH-HCC, diameter > 5.0 cm) without portal vein tumour thrombus has not been well established. This study aimed to develop novel nomograms to predict postoperative recurrence and survival of these patients. Methods: Data from 2469 patients with SLH-HCC who underwent curative resection from January 2005 to December 2015 in China were retrospectively collected. Specifically, nomograms of recurrence-free survival (RFS) and overall survival (OS) using data from a training cohort were developed with the Cox regression model (n = 1012). The modes were verified in an internal validation cohort (n = 338) and an external cohort comprising four tertiary institutions (n = 1119). Results: The nomograms of RFS and OS based on tumour clinicopathologic features (diameter, differentiation, microvascular invasion, a-fetoprotein), operative factors (preoperative transcatheter arterial chemoembolisation therapy, scope of liver resection and intraoperative blood transfusion), underlying liver albumin-bilirubin grade) and systemic inflammatory or immune status (neutrophil-to-lymphocyte ratio) achieved high C-indexes of 0.85 (95% confidence interval [CI], 0.79-0.91) and 0.86 (95% CI, 0.79-0.93) in the training cohort, respectively, which were significantly higher than those of the five conventional HCC staging systems (0.62-0.73 for RFS, 0.63-0.75 for OS). The nomograms were validated in the internal cohort (0.83 for RFS, 0.84 for OS) and external cohort (0.87 for RFS, 0.88 for OS) and had well-fitted calibration curves. Our nomograms accurately stratified patients with SLH-HCC into low-, intermediate-and high-risk groups of postsurgical recurrence and mortality. Conclusions: The two nomograms achieved optimal prediction for postsurgical recurrence and OS for patients with SLH-HCC after curative resection.
学科与关键词
- Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinomaWang, Xiao-Hui; Liu, Qing-Bo; Xiang, Cai-Ling; Mao, Xian-Hai; Yang, Bing; Li, Qiang; Zhou, Qun-Fang; Li, Shao-Qiang*; Zhou, Zhong-Guo*; Chen, Min-Shan*International Journal of Cancer, 2021, 149(1): 127-138.被引 11
- Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory MarkersHu, Zili; Yuan, Yu; Hu, Zhiwen; Liu, Qingbo; Fu, Yizhen; Hou, Jingyu; Sun, Xuqi; Li, Shaoqiang; Duan, Wenbin*; Chen, Minshan*Journal of Hepatocellular Carcinoma, 2022, 9: 1403-1413.
- Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient SurvivalMa, Lidi; Deng, Kan; Zhang, Cheng; Li, Haixia; Luo, Yingwei; Yang, Yingsi; Li, Congrui; Li, Xinming*; Geng, Zhijun*; Xie, Chuanmiao*Frontiers in Oncology, 2022, 12: 843589.被引 12
